DULUTH, Ga., Oct. 25, 2019 /PRNewswire/ -- Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced new positive real-world results from its two registry studies evaluating the Company's proprietary Sebacia Microparticles in Europe and the U.S. The results were presented at the American So

HOUSTON, Oct. 25, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today released interim clinical trial results presented at the American So

BATON ROUGE, La., Oct. 25, 2019 /PRNewswire/ -- The American Academy of Orthopaedic Manual Physical Therapists (AAOMPT) has released a position statement opposing "degenerative disc disease" as a diagnostic term for the cause of neck and back pain. AAOMPT publicly announced its position during the organization's annual conference in

SHANGHAI, Oct. 25, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2019, before the open of U.S. markets on

DUBLIN, Oct. 25, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that five new studies of XIAFLEX® (collagenase clostridium histolyticum) for the treatment of Peyronie's disease will be presented as poster presentations at the 20th Annual Fall Meeting of the Sexual Medicine Society of

WARRINGTON, Pa., Oct. 25, 2019 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today provided updates on its lead development programs and business operations.

TARRYTOWN, N.Y., Oct. 25, 2019 /PRNewswire/ -- Regeneron is the most highly ranked company over the past decadeRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the company was once again ranked as a top company to work for by Science magazine in its annual Top Employers Survey of the global biotech and pharm

VANCOUVER, Oct. 25, 2019 /PRNewswire/ - Choom™ (CSE: CHOO; OTCQB: CHOOF) is very pleased to announce the appointment of Corey Gillon as the company's new Chief Executive Officer effective Monday, December 1, 2019, and subject to provincial regulatory approvals. In addition to his executive manag

TARRYTOWN, N.Y., Oct. 25, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today celebrates its third annual Day for Doing Good, a company-wide global day of service. Reflecting Regeneron's long-standing commitment to its local communities and culture of volunteerism, thousands of company employees are participating in volunteer activitie

DUBLIN, Oct. 25, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that its Board of Directors has declared a cash dividend of $0.74 per ordinary share for the fourth quarter of 2019. The dividend will be paid on December 13, 2019 to shareholders of record at the close of business on November 13,